Results 111 to 120 of about 106,174 (376)
Left atrial (LA) contractility plays an important role in maintenance of cardiac output in patients with left ventricular systolic dysfunction. Although left atrial contractile dysfunction has been reported in dilated cardiomyopathy of ischemic and non ...
Mohammad Abdelghany Abdelzaher+4 more
doaj +3 more sources
Role of cardiac resynchronization therapy in the development of new-onset atrial fibrillation: A single-center prospective study. [PDF]
Albeit several studies examined the association between cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) in heart failure (HF), results are still unclear and quite conflicting.
Cristofaro d'+3 more
core +3 more sources
Abstract Left ventricle (LV), right ventricular (RV) structural and functional changes occurs in advanced heart failure (HF). Assessment of RV function is important as it has prognostic significance in prognosis. RV functions, depending on the underlying cause of ischemic cardiomyopathy (ICMP) or nonischemic cardiomyopathy(NICMP) are affected by ...
Göktürk İpek+4 more
openaire +2 more sources
Biomedical Applications of Gadolinium‐Containing Biomaterials: Not Only MRI Contrast Agent
This paper summarizes the latest applications and potential mechanisms of the rare earth element gadolinium in biomedical fields, in addition to its traditional application as an MRI contrast agent, including osteogenesis, antimicrobial, antitumor, bioimaging, bioprobes, and so on.
Xingtong Pan+9 more
wiley +1 more source
Overview on incidence, diagnosis, and therapy in vaccine‐related myocarditis. CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; NSAIDS, non‐steroidal anti‐inflammatory drugs. Abstract Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors, recombinant protein, and inactivated virus have been administered worldwide.
Bettina Heidecker+17 more
wiley +1 more source
Antibodies aggravate the development of ischemic heart failure [PDF]
Heart-specific antibodies have been widely associated with myocardial infarction (MI). However, it remains unclear whether autoantibodies mediate disease progression or are a byproduct of cardiac injury. To disambiguate the role of immunoglobulins in MI,
Frantz, Stefan+6 more
core +1 more source
Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy
As the most metabolically demanding organ in the body, the heart must generate massive amounts of energy adenosine triphosphate (ATP) from the oxidation of fatty acids, carbohydrates and other fuels (e.g., amino acids, ketone bodies), in order to sustain
Amanda A. Greenwell+8 more
doaj +1 more source
A Novel Approach for Identifying Ischemic Cardiomyopathy [PDF]
Refer to the page 41-47 Since Burch et al.1) first introduced the terminology "ischemic cardiomyopathy (ICM)," it has been widely used in clinical practice. The condition may originate from prolonged ischemia, a single large infarct, or repeated micro-infarcts inducing left ventricular dysfunction and remodeling through apoptosis and fibrosis as a ...
openaire +4 more sources
Is low cardiac ejection fraction a risk factor for stroke? [PDF]
Background and Purpose: Reduced ejection fraction (EF) ?35% has been suggested as a criterion for anticoagulation in persons with heart failure in sinus rhythm, but the literature supporting EF as an independent stroke risk factor is conflicting. We here
Pullicino, Patrick, Raynor, Sophie
core
PP-061 Heart failure is a cardiovascular disease that is caused by impaired left ventricular systolic and diastolic function. Ischemic and non-ischemic cardiomyopathies are the most common cause of heart failure. Its mortality is high despite to the new treatment regimens.
Engin Bozkurt+5 more
openaire +2 more sources